MedPath

Pilot Study on the Effects of Neuromuscular Taping in Parkinson's Disease Patients

Not Applicable
Completed
Conditions
Parkinson Disease
Interventions
Device: Neuromuscular taping
Registration Number
NCT03104049
Lead Sponsor
IRCCS San Raffaele Roma
Brief Summary

Parkinson's disease (PD) is a degenerative disorder characterized by a symptom triad consisting on: tremor, rigidity and bradykinesia . To these symptoms it is often added postural alteration that can stand in two different attitudes, such as the camptocormia and the syndrome of Pisa . Progressing in its evolution, PD becomes increasingly disabling, making it difficult or even impossible daily activities such as washing or dressing.The abnormal posture, with alteration of the limbs, the neck and trunk, is a recurring feature in PD, with a frequency of about 30%. Between 2% and 12.3% are more severe abnormalities such as camptocormia, the syndrome of Pisa and the anterocollis. Several studies disease plug in Neuromuscular Taping technique (NMT) among rehabilitative tools in degenerative neurological syndromes.

To the best of our knowledge, no applications were found in PD. Therefore, the current study was designed to evaluate quantitatively the effects of the NMT intervention on the trunk kinematics during standing position. More specifically, this study aims to compare the trunk kinematic variables of patients with PD who were treated with effective NMT versus those of the subjects who received only the pharmacological treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
the PD NMT GroupNeuromuscular tapingthe NMT Group were treated with NMT
Primary Outcome Measures
NameTimeMethod
Change in the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) rating scale total score between baseline evaluations and end of treatmentbaseline and end of treatment (1 month)

Clinical measures were summarized as means and standard deviations for all the 46 patients.

Secondary Outcome Measures
NameTimeMethod
Change in the EuroQol 5 total score between baseline evaluations and end of treatmentbaseline and end of treatment (1 month)

Clinical measures were summarized as means and standard deviations for all the 46 patients.

Change in the Non Motor Symptoms scale total score between baseline evaluations and end of treatmentbaseline and end of treatment (1 month)

Clinical measures were summarized as means and standard deviations for all the 46 patients.

Change in the Freezing of Gait total score between baseline evaluations and end of treatmentbaseline and end of treatment (1 month)

Clinical measures were summarized as means and standard deviations for all the 46 patients.

Change in the Parkinson Disease Quality of life 8 total score between baseline evaluations and end of treatmentbaseline and end of treatment (1 month)

Clinical measures were summarized as means and standard deviations for all the 46 patients.

© Copyright 2025. All Rights Reserved by MedPath